Cambridge, UK-based Napp Pharmaceuticals has launched flutiform k-haler, a new asthma product. The firm says it is planning further launches across Europe in the next months.
The product uses a patented ‘kinked’ valve to make it easier for patients to use correctly.
The firm’s medical director Paul Schofield said: “The flutiform k-haler has been designed with patients in mind, requiring only a gentle inhalation to trigger the dose release, with the aim to help patients reduce critical errors and improve long-term outcomes.”
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze